Connect with us

Technology

PocDoc expands across Community Pharmacy, powering digital Health Checks

Published

3 years ago

on

CAMBRIDGE, England, April 28, 2023 /PRNewswire/ — PocDoc, the Cambridge-based digital health platform today announces it has launched in 4 major community pharmacy chains across the UK, giving it access to over 300 locations nationwide.

In addition to Dears Pharmacy in Scotland, PocDoc is now partnered with Knights Pharmacy Group, Weldricks Pharmacy Group, Greenlight Pharmacy Group and Lincolnshire Co-op Pharmacy.

Across its partnership network, PocDoc is being used both in pharmacy and out of pharmacy in the community, targeting areas of health inequality to dramatically increase cholesterol testing, either as part of existing blood pressure clinics or as a standalone Health Check service.

Cardiovascular Disease has been identified as the single biggest condition where lives can be saved by the NHS over the next decade and the Company Chemist Association estimates that pharmacies alone can save 15,000 heart attacks and strokes in the next 3 years through focusing on CVD prevention measures1.

The evidence is clear: the more people tested, the more people can be treated and the more heart attacks and strokes can be prevented.

PocDoc is an app-based technology platform that combines proprietary lateral flow tests and cloud-based AI diagnostics to deliver end to end digital pathways for the assessment, diagnosis and treatment of major diseases. 

PocDoc is able to deliver the full end-to-end cardiovascular Health Check pathway, including a quantified, lab-grade 5 marker lipid (cholesterol) test with results in the app, in under 10 minutes per person.

The PocDoc app collects all the information required for a Health Check, including blood pressure and BMI. The app displays all results, including blood marker values, in a health dashboard with comparison to NHS clinical guidelines.

The patient receives a copy of their results emailed to them automatically and results can be sent to the patient’s record from PocDoc’s diagnostic cloud.  The pharmacy can also access the PocDoc clinical dashboard to assess future treatment pathways in real time, including prescription of statins where appropriate.

The PocDoc solution consists of a proprietary lateral flow test combined with an app downloaded onto a smartphone or tablet – it’s convenient for busy pharmacies with space constraints, it requires no calibration nor maintenance and there is no cost for large machines.

In addition to a growing pharmacy customer base, PocDoc has recently been awarded 2 major NHS contracts to dramatically increase access to cholesterol testing outside of a traditional GP surgery environment, including at-home, on the high street and in other community settings.

In March, PocDoc announced a major round of investment led by Forward Partners, MMC Ventures and Simplyhealth, one of the UK’s leading health insurance providers.

Steve Roest, CEO of PocDoc, says, “We are excited to announce our continued expansion in Community Pharmacy. We strongly believe that Community Pharmacies have a major role to play in delivering a step change increase in access to cardiovascular screening, both in pharmacy and in community settings. We’re pleased that PocDoc has seen such positive reactions from pharmacists and their customers across the UK and we are proud to support our pharmacy partners in their incredible efforts to improve their health of their customers.”

“Knights Pharmacy plays a critical role across the UK in providing services to those most in need in the community. We are always looking for new services that address key health issues for the public and the NHS so we are pleased to be rolling out the PocDoc cholesterol test and health screening app as part of our mobile health clinic, targeting areas of greatest health inequality.” – Pete Horrocks, Clinical Standards Director, Knights Pharmacy.

“Weldricks has a strong and proud reputation throughout its history of delivering services to customers that make a real difference and address their health concerns. Recently, it has become clear that heart and cardiovascular health is a big concern for both our customers and the NHS. We are pleased to be rolling out the PocDoc quantitative cholesterol test, we feel it’s the right product for pharmacy and for customers.” – Richard Hackett – Head of Pharmacy, Weldricks Pharmacy.

“As one of the leading London-based independent chains, we are seeing a huge rise in demand for services such as health checks from customers, including cholesterol testing. PocDoc is able to deliver a digital-first health check with a cholesterol test in a really patient friendly, pharmacy friendly way and we’re excited to offer it across our estate.” – Paras Shah, Lead Pharmacist, Greenlight Pharmacy Group.

Notes to Editors

Available for interview on request:

Steve Roest – CEO & Co-Founder, PocDoc

To book in an interview or for more information please contact: comms@mypocdoc.com

1About Cardiovascular Disease:

There are 7.6 million people living with CVD in the UK, and Cardiovascular Disease is a leading cause of premature disability, mortality, and health inequalities, and responsible for one in four deaths each year. 

(https://www.bhf.org.uk/what-we-do/news-from-the-bhf/contact-the-press-office/facts-and-figures#:~:text=Heart%20and%20circulatory%20diseases%20cause,men%20and%203.6%20million%20women.)

The UK Health Security Agency estimates that the annual healthcare costs in England relating to CVD are around £7.4 billion, with an annual cost to the wider economy of £15.8 billion. 

(https://ukhsa.blog.gov.uk/2019/02/14/health-matters-preventing-cardiovascular-disease/).

Company Chemist Association reference article: https://www.chemistanddruggist.co.uk/CD136951/CCA-Hypertension-case-finding-service-to-halt-15k-cardiovascular-events-by-2026

About PocDoc:

Founded by Dr Kiran Roest, Dr Vladimir Gubala and Steve Roest, PocDoc’s mission is to make diagnostic testing as accessible and affordable as possible. The PocDoc platform allows anyone with a smartphone or tablet to test themselves for a range of major diseases and conditions, receive a full health assessment and be offered solutions to address any health-related issues that arise, including real-time prescription of medication and clinical support.

The PocDoc® platform has been designed to work with the company’s own set of proprietary, quantitative blood tests which have been developed in house and are focused on preventative disease areas, starting with cardiovascular disease.

PocDoc has a number of NHS contracts, has won multiple Innovate UK awards, an SBRI award and a MedTech Breakthrough Award.

Its technology has CA and CE marks and is patented in Europe and the US.  

www.mypocdoc.co.uk 

About Steve Roest:

Steve is the CEO and founder of PocDoc, where he has raised multiple rounds of private investment, is a multiple time Innovate UK grant award winner, as well as a member of the UK Research and Innovation Future Leaders review board.

Steve is a huge advocate for innovation and pushing boundaries of what is possible with technology. He is passionate about the people and companies who are changing the world, especially in HealthTech and Healthcare.

Steve presents the HealthTech Hour on UK Health Radio which was born from his desire to provide a showcase for companies, leaders, founders, CEOs and clinicians who are genuinely changing the world, leading the healthcare revolution in the UK and beyond. Notable guests include Matt Hancock, Ali Parsa and Jessica Ennis Hill among others.

The show, which has over 60,000 listeners live per week from over 30 countries, with more listening on demand via Spotify, Apple, Amazon Music and Google Podcasts and YouTube, focuses on the unique journeys of each guest, how they are changing the world and how they stay on their mission.

www.healthtechhour.co.uk

https://www.youtube.com/@healthtechhour

https://open.spotify.com/show/5pZb65BCLauYxbJrbzDQfP?si=4229d00f85ec4b84 

Video: https://www.youtube.com/watch?v=QJ7p_oiTrIY
Photo: https://mma.prnewswire.com/media/2064863/PocDoc_PR_Image.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/pocdoc-expands-across-community-pharmacy-powering-digital-health-checks-301810510.html

Related Topics:
Continue Reading

Technology

LEAP Group Relaunches HumanView, a Growth Intelligence System Built to Explain Why Customers Behave the Way They Do

Published

2 hours ago

on

October 24, 2026

By

Reimagined from the ground up, HumanView pairs statistical modeling with expert analysts to turn millions of real-world customer signals into business decisions

LOUISVILLE, Ky., Oct. 23, 2026 /PRNewswire/ — LEAP Group today announced the relaunch of HumanView, its growth intelligence service. The new version has been rebuilt from the ground up and now has a dedicated home at leapgroupnetwork.com/humanview.

HumanView analyzes what customers say and do across social platforms, e-commerce sites, review platforms, search behavior and user-generated content, including signals from Reddit, TikTok, YouTube, Meta, Amazon and Walmart+ that general AI tools cannot always access. Because the data reflects unprompted, real-world behavior, it avoids the response bias built into surveys and focus groups.

The service works in three layers. HumanView captures signals at scale, decodes millions of records through validated statistical models such as regression, correlation and clustering, and then relies on experienced analysts to interpret the patterns. Clients receive clear, human-validated insights instead of another dashboard.

“Machines find the patterns. Humans find the point,” said Alan Gilleo, CEO at LEAP Group. “The first version of HumanView showed us how much customers reveal when nobody is asking them questions. This version is built to explain why they act the way they do, and to put those answers in front of everyone making decisions, from product to service to marketing.”

HumanView focuses on three areas:

Growth Intelligence: customer motivations and how people perceive a brand and its competitors

Market and Category Intelligence: product pain points, service friction, unmet needs and competitive gaps

Audience Intelligence: new segments, positioning opportunities and gaps in the market

Every model is designed and validated by data scientists and benchmarked before it informs a recommendation.

To learn more about HumanView, visit leapgroupnetwork.com/humanview.

About LEAP Group
LEAP Group is a boutique marketing agency holding company with offices in Louisville, Indianapolis, Cincinnati and Chicago. Guided by the belief that brands should “Market Less. Matter More.,” LEAP gives clients access to specialized experts across its entire network. Learn more at leapgroupnetwork.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-group-relaunches-humanview-a-growth-intelligence-system-built-to-explain-why-customers-behave-the-way-they-do-302918557.html

SOURCE LEAP Group

Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

3 hours ago

on

October 24, 2026

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

3 hours ago

on

October 24, 2026

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Trending